Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phuong L Mai

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2015
The fallopian tube: from back stage to center stageMark H Greene, Phuong L Mai
Breast Cancer Research and Treatment|March 11, 2011
Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancerCatherine Schairer, Linda M Brown, Phuong L Mai
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Challenges related to developing serum-based biomarkers for early ovarian cancer detectionPhuong L Mai, Nicolas Wentzensen, Mark H Greene
American Journal of Obstetrics and Gynecology|July 13, 2010
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Mark H Greene, Phuong L Mai, Peter E Schwartz
Best Practice & Research. Clinical Endocrinology & Metabolism|September 14, 2010
Familial testicular germ cell tumoursChristian P Kratz, Phuong L Mai, Mark H Greene
Journal of Genetic Counseling|January 8, 2024
Release of reclassified VUS results of now deceased patients to family members: Practices and opinionsSeth Lascurain, Darcy Thull, Andrea Durst, et al.
Annals of Surgical Oncology|October 7, 2008
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessmentPhuong L Mai, Veronica I Lagos, Melanie R Palomares, et al.
JCO Precision Oncology|January 13, 2022
Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current PracticeMegan A Czekalski, Rachelle C Huziak, Andrea L Durst, et al.
Journal of Genetic Counseling|December 2, 2015
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni SyndromeJune A Peters, Regina Kenen, Renee Bremer, et al.
American Journal of Preventive Medicine|April 22, 2014
Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview SurveysPhuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2015
The fallopian tube: from back stage to center stageMark H Greene, Phuong L Mai
Breast Cancer Research and Treatment|March 11, 2011
Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancerCatherine Schairer, Linda M Brown, Phuong L Mai
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Challenges related to developing serum-based biomarkers for early ovarian cancer detectionPhuong L Mai, Nicolas Wentzensen, Mark H Greene
American Journal of Obstetrics and Gynecology|July 13, 2010
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Mark H Greene, Phuong L Mai, Peter E Schwartz
Best Practice & Research. Clinical Endocrinology & Metabolism|September 14, 2010
Familial testicular germ cell tumoursChristian P Kratz, Phuong L Mai, Mark H Greene
Journal of Genetic Counseling|January 8, 2024
Release of reclassified VUS results of now deceased patients to family members: Practices and opinionsSeth Lascurain, Darcy Thull, Andrea Durst, et al.
Annals of Surgical Oncology|October 7, 2008
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessmentPhuong L Mai, Veronica I Lagos, Melanie R Palomares, et al.
JCO Precision Oncology|January 13, 2022
Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current PracticeMegan A Czekalski, Rachelle C Huziak, Andrea L Durst, et al.
Journal of Genetic Counseling|December 2, 2015
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni SyndromeJune A Peters, Regina Kenen, Renee Bremer, et al.
American Journal of Preventive Medicine|April 22, 2014
Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview SurveysPhuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, et al.
Pageof 11